Personalized Variable Versus Fixed Dose Glucocorticoid Therapy in AECOPD
Status:
Completed
Trial end date:
2018-04-01
Target enrollment:
Participant gender:
Summary
The hypothesis is that in acute exacerbated Chronic Obstructive Pulmonary Disease (AECOPD),
personalized variable dose glucocorticoid treatment will result in superior clinical outcome
when compared to fixed dose therapy.
Phase:
N/A
Details
Lead Sponsor:
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University